Xeno Pharmaaceuticals Private Limited, a active private limited company, was established on 27 March 2009 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33112TN2009PTC071160. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹4.00 M.
It upholds a compliant status. Employing 8 professional, Its leadership includes Palani Vel Sakthivel (Managing Director), Muthukrishnan Mahendrakumar (Director). Past directors included Palani Vel Sakthivel, Muthukrishnan Mahendrakumar. It holds ₹2.00 Cr open charges and ₹1.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No 87 A 8Th Street, Shree Kumaran Nagar, Kovur, Chennai, Tamil Nadu, 600128.
U33112TN2009PTC071160
071160
27 March 2009
₹4.00 M
₹4.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Xeno Pharmaaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Palani Vel Sakthivel | Managing Director | 27 Mar 2009 | Current |
| Muthukrishnan Mahendrakumar | Director | 27 Mar 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Oct 2018 | Past |
| Pramod Abcsdd | Managing Director | 12 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Xeno Pharmaaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.07% decrease. The company also saw a substantial fall in profitability, with a 35.75% decrease in profit. The company's net worth moved up by a moderate rise of 3.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Xeno Pharmaaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹15,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2021 | Others | ₹1.00 Cr | Open |
| 07 Jun 2021 | Others | ₹1.00 Cr | Open |
| 27 Jun 2016 | Others | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Xeno Pharmaaceuticals has a workforce of 8 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Xeno Pharmaaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xeno Pharmaaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Xeno Pharmaaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Xeno Pharmaaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
A charge with Others amounted to Rs. 10.00 M with Charge ID 100454153 was registered on 22 Jun 2021. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 10.00 M with Charge ID 100451387 was registered on 07 Jun 2021. was completed.
The activity A charge registered on 27 Jun 2016 via Charge ID 100066630 with Others was fully satisfied on 19 Mar 2021. was completed.
A charge with Others amounted to Rs. 15.00 M with Charge ID 100066630 was registered on 27 Jun 2016. was recorded as a recent event.
The CIN of Xeno Pharmaaceuticals Private Limited is U33112TN2009PTC071160.
Xeno Pharmaaceuticals Private Limited is headquartered at No 87 A 8Th Street, Shree Kumaran Nagar, Kovur, Chennai, Tamil Nadu, 600128.
Xeno Pharmaaceuticals Private Limited was incorporated on 27 March 2009.
The current directors of Xeno Pharmaaceuticals Private Limited are
The primary industry of Xeno Pharmaaceuticals Private Limited is Trade.
Xeno Pharmaaceuticals Private Limited is unlisted.
The authorized capital of Xeno Pharmaaceuticals Private Limited is ₹4.00 M, and the paid-up capital is ₹4.00 M.
The compliance status of Xeno Pharmaaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX